NCT05652777|Completed
Feasibility of Using NeoSpot at Community Settings
Feasibility of Vital Sign Assessment by Community Health Workers During Antenatal Care Community Outreach
Loading search results
Feasibility of Vital Sign Assessment by Community Health Workers During Antenatal Care Community Outreach
Sponsor study identifier
observational
149
1 country
1
Study Start
January 15, 2023
Actual (reported)Primary Completion
April 30, 2024
Actual (reported)Study Completion
April 30, 2024
Actual (reported)Continuous vital sign monitoring is a basic tenet of specialized care in the developed world that is vastly underutilized during hospital or clinic admissions or outpatient routine visits in most low-and-middle income countries (LMICs). Despite the positive outcomes associated with vital sign monitoring (i.e., increased survival-to-discharge rates, lower complication rates and shorter length of stay in hospital), the prohibitive costs of conventional patient monitors and the difficulty in maintaining complex medical equipment limit its practice in the developing world. Currently, due to lack of medical supplies, most ANC clinics - within the health facilities or during outreach activities - do not monitor for vital signs and blood pressure among pregnant women. While many devices exist, their ease of use and high-cost, including maintenance costs, hinder screening and monitoring programs in low resource settings. Accurate and low-cost vital sign monitoring devices are required to improve identification and treatment of women with danger signs during their routine ANC visits. To meet the growing demand for vital sign monitors during the COVID-19 pandemic, Neopenda has adapted an affordable, wearable, wireless vital sign monitoring solution (neoSpotTM), that measures temperature, respiration rate, blood oxygen saturation, pulse rate, and blood pressure.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
April 30, 2024
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
September 13, 2022
Actual (reported)December 15, 2022
Actual (reported)January 15, 2023
Actual (reported)April 30, 2024
Actual (reported)April 30, 2024
Actual (reported)Feasibility of using a wearable, wireless vital sign monitoring solution NeoSpot device by Community Health Workers (CHWs)
To describe the feasibility of CHWs to use the NeoSpot device during community ANC outreach through in-depth interviews
Baseline to day 1
Acceptability of using a wearable, wireless vital sign monitoring solution NeoSpot device by Community Health Workers (CHWs)
To describe the acceptability of CHWs to use the NeoSpot device during community ANC outreach through in-depth interviews
Baseline to day 1
Acceptability of using a wearable, wireless vital sign monitoring solution NeoSpot device by pregnant women
Baseline to day 1
Collect photoplethysmograph (PPG) data using a wearable, wireless vital sign monitoring solution NeoSpot device
Baseline to day 1
Pregnant women attending antenatal care clinic during routine community outreach activities in Lusaka, Zambia.
Pregnant women will undergo screening of their vital signs using the NeoSpot device.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Pregnant women residing at Kanyama compound and attending ANC care during routine community outreach activities will be approached, screened, and consented for study participation. Community Health Workers who have used the device on enrolled study participants (pregnant women) will under-go in-depth interviews.
Kanyama First Level Hospital
Lusaka, Lusaka Province, 10101, Zambia
Albert Manasyan, MD
Center for Infectious Disease Research in Zambia (CIDRZ)
149 participants (actual enrollment reported by the registry).
First Submitted
September 13, 2022
First Posted
December 15, 2022
Study Start
January 15, 2023
Actual (reported)Effect of Adding Pelvic Floor Exercises to the Stabilization Exercises in Treating Low Back Pain During Pregnancy
Contact the study team to confirm eligibility.
Primary Completion
April 30, 2024
Actual (reported)Study Completion
April 30, 2024
Actual (reported)Last Updated
September 25, 2026
Record last verified: 2026-09
De-identified study data will be available to other researchers upon reasonable request to the study PI.
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: